Cargando…
Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer
Current treatment options for head and neck squamous cell carcinoma (HNSCC) patients are often ineffective due to tumor-localized and systemic immunosuppression. Using the 4-NQO mouse model of oral carcinogenesis, this study showed that premalignant oral lesion cells produce higher levels of the imm...
Autores principales: | Johnson, Sara D., Young, M. Rita I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031768/ https://www.ncbi.nlm.nih.gov/pubmed/27713748 http://dx.doi.org/10.3389/fimmu.2016.00379 |
Ejemplares similares
-
An Inflammatory Cytokine Milieu is Prominent in Premalignant Oral Lesions, but Subsides when Lesions Progress to Squamous Cell Carcinoma
por: Woodford, Danielle, et al.
Publicado: (2014) -
Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD‐1 antibodies
por: Levingston, Corinne A., et al.
Publicado: (2017) -
Role of IL-23 signaling in the progression of premalignant oral lesions to cancer
por: Caughron, Blaine, et al.
Publicado: (2018) -
Effect of the Premalignant and Tumor Microenvironment on Immune Cell Cytokine Production in Head and Neck Cancer
por: Johnson, Sara D., et al.
Publicado: (2014) -
Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination
por: Zachariah, Nadia Nocera, et al.
Publicado: (2021)